Reliability and Validity of the Surgimap Software for Measuring Quadriceps Angle in Healthy Subjects

February 19, 2024 updated by: Aida Amir Nassif Naguib, Cairo University
The purpose of this study is to investigate the intra- and inter-rater reliability and concurrent validity of surgimap software for measuring the Q angle Surgimap (Nemaris Inc, New York, NY, USA) is a dedicated spine measurement and surgical planning software which is used in both the research works and the clinical rehabilitation. Q angle is considered to be an index of the vector for action of the patellar tendon and extensors mechanism which is highly affects the patellofemoral joint dysfunction and foot mechanics.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

specialised software for assessing the sagittal plane has arisen. Digital measuring software of many types has been proved to be faster, more accurate, more precise, and less variable than manual procedures. Angle measurement software is available in different formats and applications. Surgimap is another programme used for measuring angles. The current software has proven to be a godsend and is currently being used in the medical industry to measure joint angles especially the spine alignment. The programme is also used for scientific reasons, such as digital photo analysis. A recent study discovered that Surgimap software is a viable approach for evaluating spinal postural angles in teenagers from varied standing position perspectives using digital pictures.

As there a lack of knowledge about the reliability and validity of the surgimap software to measure the Q- angle. Therefore, The study will investigate the inter-rater, intra-rater reliability and concurrent validity of the surgimap software for measuring the Q-angle.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Giza, Egypt, 11432
        • Faculty of Physical Therapy, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

This study will be conducted in the out-patient clinic Faculty of physical therapy, Cairo University. The expected duration to recruit patients and collect data is 3 months .

Description

Inclusion Criteria:

  • Both male & female
  • Aged 18:25
  • BMI 18.5: 25
  • Normal foot posture as assessed by foot posture index.

Exclusion Criteria:

  • Subjects who have operations in the knee joint
  • Subjects who have traumatic knee injury
  • High arched or low arched foot.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The inter-rater, intra-rater reliability and concurrent validity of the surgimap software for measuring the Q-angle.
Time Frame: 3 months
the accuracy and consistency of surgimap software for measuring the q angle
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Investigators

  • Principal Investigator: Aida Nassif, PHD, lecturer of physical therapy, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2023

Primary Completion (Actual)

January 30, 2024

Study Completion (Actual)

January 30, 2024

Study Registration Dates

First Submitted

August 19, 2023

First Submitted That Met QC Criteria

August 19, 2023

First Posted (Actual)

August 24, 2023

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 19, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • P.T.REC/012/004538

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe